Addition of aprepitant improves acute emesis control in children and adolescents receiving induction chemotherapy for acute myeloid leukaemia: a randomised, open-label trial.
Atul SharmaShuvadeep GangulySantosh Kumar CAshwati S PillaiDeepa DhawanVishnubhatla SreenivasSameer BakhshiPublished in: BMJ supportive & palliative care (2020)
The study was registered at ClinicalTrials.gov (NCT02979548).
Keyphrases
- open label
- liver failure
- clinical trial
- phase iii
- study protocol
- phase ii
- respiratory failure
- drug induced
- aortic dissection
- phase ii study
- double blind
- randomized controlled trial
- dendritic cells
- acute myeloid leukemia
- hepatitis b virus
- squamous cell carcinoma
- intensive care unit
- extracorporeal membrane oxygenation
- radiation therapy